Role of leptin on alcohol-induced oxidative stress in Swiss mice

https://doi.org/10.1016/S1043-6618(02)00317-1Get rights and content

Abstract

Previous studies suggest a possible link between leptin and hepatic inflammation; however, the role of leptin on liver disease remain unclear. The purpose of the present study was to evaluate the effect of leptin on tissue lipid peroxidation and the antioxidant status in experimental hepatotoxicity. Administering ethanol (6.32 g/kg body weight) to 4-week-old healthy mice for 45 days resulted in significantly elevated levels of tissue thiobarbituric acid reactive substances (TBARS), conjugated dienes (CD) and lowered activities of superoxide dismutase (SOD), catalase (CAT), reduced glutathione (GSH) and glutathione related enzymes such as glutathione peroxidase (GPx) and glutathione S-transferase (GST) as compared with those of the control mice. subsequent to the experimental induction of hepatotoxicity (i.e. after the initial period of 30 days) exogenous leptin was simultaneously administered (230 μg/kg body weight) every alternate day for 15 days along with the daily dose of alcohol. Leptin administration to control and alcohol-treated mice significantly reduced the weight gain, significantly elevated the liver and kidney levels of TBARS and CD, and significantly lowered the levels of enzymic and non-enzymic antioxidants as compared with the untreated control and alcohol supplemented mice. It is postulated that the increase in systemic leptin levels enhance the oxidative stress, and lower the antioxidant defence, leading to augmented hepatic inflammation in alcoholic liver disease.

Introduction

Lipid peroxidation mediated by free radicals is considered to be a primary mechanism of cell membrane destruction and cell damage [1]. One of the most thoroughly investigated examples is the lipid peroxidation stimulated by the model hepatotoxin-ethanol. There appears to be increasing evidence that alcohol toxicity may be associated with increased oxidative stress and free radical associated injury [2]. Generation of oxygen metabolites such as superoxide (O2) hydrogen peroxide (H2O2) and hydroxyl radicals (OH) is believed to be important in the pathogenesis of alcoholic liver injury [3]. To counteract these oxidants, cells have several antioxidant enzymes including superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT).

Leptin is a 167-amino acid cytokine-like peptide, synthesized by adipocytes and secreted into the blood stream. Administration of leptin to ob/ob mice lowered their body weight, percent body fat and food intake as well as enhanced their energy expenditure. These effects strongly implicated leptin as a negative feed back signal, which reflects body adiposity by acting at the hypothalamic level [4].

Recently, it was reported that leptin is produced not only by adipose tissues but also by other tissues, including stomach [5]. Interestingly, isolated hepatic stellate cells have been shown to produce leptin during the in vitro transactivation process [6]. Further, it has been reported that serum leptin levels are increased in patients with alcohol-induced cirrhosis [7], [8]. These observations suggested a possible involvement of leptin in the pathogenesis of liver diseases. Moreover, clinical studies have disclosed that obesity is a risk factor for the progression of chronic liver diseases including viral hepatitis [9], alcohol-induced liver disease [10], and non-alcoholic steato hepatitis [11]. Although obese people show obvious hyperleptinemia [12], it is still unclear whether an increase in systemic leptin levels is involved in the progression of liver diseases. In the present study, therefore, we evaluated the effect of administering exogenous leptin on tissue lipid peroxidation and the enzymic and non-enzymic antioxidants in alcohol-induced liver injury in mice.

Section snippets

Materials

Recombinant mouse leptin (expressed in E. coli) was purchased from Sigma Chemical Co., St. Louis, MO, USA. The OB protein showed more than 95% purity as evidenced by SDS–PAGE and HPLC analyses. Leptin was dissolved in phosphate-buffered saline at pH 7.4 just before use.

Thiobarbituric acid, 1,1′,3,3′-tetra-methoxy propane were purchased from Ranbaxy (p) Ltd., Mumbai, India. 5,5′-Dithiobis (2-nitro benzoic acid), phenazine methosulphate and reduced nicotinamide adenine dinucleotide (NADH) were

Results

Lipid peroxidation and the different enzymic and non-enzymic antioxidants in the liver, brain and kidney of mice in the control and experimental groups were examined and the data are represented in the tables.

Table 1 shows the average weight gained by the animals during the total experimental period of 45 days. The weight gain was significantly reduced in alcohol-treated mice (group 3) as compared to the control animals (group 1). Exogenous leptin administration to the control and

Discussion

Proper nutritional status is critical for maintaining growth and metabolic function, playing an intimate role in neuroendocrine regulation. Hypothalamus is the primary target organ of leptin, where it inhibits the release of neuropeptide Y, an appetite stimulator, thus effectively reducing food intake. Leptin also decreases appetite by stimulating the production of corticotropin releasing hormone. Additionally, leptin stimulates sympathetic nerve activity which increases metabolic rate [21].

Conclusion

Our experimental data suggest that leptin augments alcohol-induced lipid peroxidation by lowering the levels of enzymic and non-enzymic antioxidants. These findings may account for the relationship between obesity, steatosis and progression of chronic liver diseases. Recently, obesity has been recognized as a risk factor for the development of chronic liver diseases caused by a variety of etiologies including chronic hepatitis [10], alcohol [11], and non-alcoholic fatty liver disease [12].

References (39)

  • V. Ratziu et al.

    Liver fibrosis in overweight patients

    Gastroenterology

    (2000)
  • A. Poonawala et al.

    Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case control study

    Hepatology

    (2000)
  • G.L. Plaa et al.

    Chemicals, drugs and lipid peroxidation

    Ann. Rev. Pharmacol. Toxicol.

    (1976)
  • R.G. Thurman et al.

    New perspectives in catalase-dependent ethanol metabolism

    Drug Metab. Rev.

    (1989)
  • M.A. Pelleymounter et al.

    Effects of the obese gene product on body weight regulation in ob/ob mice

    Science

    (1995)
  • A. Bado et al.

    The stomach is a source of leptin

    Nature

    (1998)
  • J.H. Henriksen et al.

    Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal

    Hepatology

    (1999)
  • L.F. Hourigan et al.

    Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

    Hepatology

    (1999)
  • A.M. Diehl

    Nonalcoholic steatohepatitis

    Semin. Liver Dis.

    (1999)
  • Cited by (0)

    View full text